These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Pharmacology of enkephalinase inhibitors: animal and human studies. Ehrenpreis S Acupunct Electrother Res; 1985; 10(3):203-8. PubMed ID: 2866674 [TBL] [Abstract][Full Text] [Related]
15. Phosphoramidon potentiates the increase in lung resistance mediated by tachykinins in guinea pigs. Thompson JE; Sheppard D Am Rev Respir Dis; 1988 Feb; 137(2):337-40. PubMed ID: 2449105 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat. Cellier E; Barbot L; Regoli D; Couture R Br J Pharmacol; 1997 Oct; 122(4):643-54. PubMed ID: 9375960 [TBL] [Abstract][Full Text] [Related]
17. Cholecystokinin octa- and tetrapeptide degradation by synaptic membranes. III. Inactivation of CCK-8 by a phosphoramidon-sensitive endopeptidase. Deschodt-Lanckman M; Koulischer D; Przedborski S; Lauwereys M Peptides; 1984; 5(3):649-51. PubMed ID: 6089150 [TBL] [Abstract][Full Text] [Related]
18. Enkephalinase inhibitor potentiates substance P- and capsaicin-induced bronchial smooth muscle contractions in humans. Honda I; Kohrogi H; Yamaguchi T; Ando M; Araki S Am Rev Respir Dis; 1991 Jun; 143(6):1416-8. PubMed ID: 1710881 [TBL] [Abstract][Full Text] [Related]